Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-06

Clinical Trial Update: REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial REDI-CaP investigates recovery of erectile dysfunction in prostate cancer patients; the study is currently active but not recruiting. Spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Prostate Cancer (Adenocarcinoma) | Phase 2 | Status: ACTIVE_NOT_RECRUITING